We are live on
!
Find out more
HP
Hikari Power Portfolio holdings
AUM
$855M
1-Year Est. Return
14.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$855M
AUM Growth
-$293M
(-26%)
Cap. Flow
-$319M
Cap. Flow
% of AUM
-37.38%
Top 10 Holdings %
Top 10 Hldgs %
90.68%
Holding
53
New
2
Increased
–
Reduced
18
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$827K |
| 2 |
TG Therapeutics
TGTX
|
+$205K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$59.1M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$47.6M |
| 3 |
Johnson & Johnson
JNJ
|
+$35.1M |
| 4 |
Danaher
DHR
|
+$29.9M |
| 5 |
Shell
SHEL
|
+$27.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 70.91% |
| 2 | Energy | 7.31% |
| 3 | Healthcare | 7.14% |
| 4 | Communication Services | 4.89% |
| 5 | Materials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Corvus Pharmaceuticals
CRVS
$1.21B
| $746K | 0.09% |
49,959
| – | – |
|
|
27
Zoetis
ZTS
$31.3B
| $632K | 0.07% |
+8,790
| New | +$827K |
|
28
Fortive
FTV
$17.2B
| $473K | 0.06% |
7,750
| – | – |
|
29
Wells Fargo
WFC
$272B
| $455K | 0.05% |
5,500
-1,500
| -21% | -$121K |
|
30
Agilent Technologies
A
$42.5B
| $448K | 0.05% |
3,370
| – | – |
|
31
Veeva Systems
VEEV
$44.5B
| $405K | 0.05% |
2,280
| – | – |
|
32
IDEX
IEX
$16.5B
| $377K | 0.04% |
1,660
| – | – |
|
33
Solventum
SOLV
$15.6B
| $362K | 0.04% |
4,697
| – | – |
|
34
Lockheed Martin
LMT
$121B
| $352K | 0.04% |
690
| – | – |
|
35
Mettler-Toledo International
MTD
$27B
| $300K | 0.04% |
235
| – | – |
|
36
3M
MMM
$86.9B
| $285K | 0.03% |
1,760
| – | – |
|
|
37
TG Therapeutics
TGTX
$8.57B
| $275K | 0.03% |
+5,000
| New | +$205K |
|
38
Brookfield
BN
$90B
| $262K | 0.03% |
6,150
| – | – |
|
39
Ecolab
ECL
$78.3B
| $254K | 0.03% |
910
| – | – |
|
40
Vanguard Health Care ETF
VHT
$19.3B
| $251K | 0.03% |
840
| – | – |
|
41
Anavex Life Sciences
AVXL
$265M
| $222K | 0.03% |
85,585
| – | – |
|
42
Ocular Therapeutix
OCUL
$2.34B
| $167K | 0.02% |
17,000
| – | – |
|
43
Aldeyra Therapeutics
ALDX
$89.3M
| $43K | 0.01% |
20,020
| – | – |
|
44
Bank of America
BAC
$438B
| – | – |
-40,240
| Closed | -$1.96M |
|
45
Becton Dickinson
BDX
$50.3B
| – | – |
-23,970
| Closed | -$3.77M |
|
46
BHP
BHP
$230B
| – | – |
-147,400
| Closed | -$10.7M |
|
47
Gilead Sciences
GILD
$187B
| – | – |
-18,630
| Closed | -$2.6M |
|
48
Coca-Cola
KO
$379B
| – | – |
-48,400
| Closed | -$3.68M |
|
49
Mastercard
MA
$507B
| – | – |
-10,000
| Closed | -$5M |
|
50
Altria Group
MO
$115B
| – | – |
-196,060
| Closed | -$12.9M |
|
Similar funds
EWA
DCM
BC
QIM
AIMC
F
AAM
UBV
Hikari Power's Q2 2026 Portfolio in Review
As of Q2 2026, Hikari Power held 53 positions worth $855M, down 26% from $1.15B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Hikari Power withdrew a net $319M in Q2 2026, closing 10 positions and reducing 18 holdings. Its most notable exit was Altria Group, an estimated $12.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 71% of assets, up from 57% a quarter earlier, followed by Energy and Healthcare.
Against the trend, Hikari Power opened a new position in Zoetis worth $632K.
- Hikari Power's largest Q2 2026 buy was Zoetis: 8,790 shares worth $632K.
- Hikari Power's biggest Q2 2026 reduction was Linde, cutting an estimated $59.1M.
- Hikari Power fully exited Altria Group in Q2 2026, selling an estimated $12.9M.
- Hikari Power's ten largest holdings make up 91% of its $855M portfolio in Q2 2026.
- Hikari Power opened 2 new positions and closed 10 in Q2 2026.
- Hikari Power's portfolio value fell 26% quarter-over-quarter to $855M.
Based on Hikari Power's 13F filing for Q2 2026, filed 7 Aug 2026.